NASDAQ:RPID Rapid Micro Biosystems (RPID) Stock Price, News & Analysis $0.82 -0.06 (-6.47%) Closing price 04:00 PM EasternExtended Trading$0.82 +0.00 (+0.09%) As of 04:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOwnershipSEC Filings About Rapid Micro Biosystems Stock (NASDAQ:RPID) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Rapid Micro Biosystems alerts:Sign Up Key Stats Today's Range$0.81▼$0.8850-Day Range$0.86▼$2.1152-Week Range$0.81▼$4.94Volume145,102 shsAverage Volume236,637 shsMarket Capitalization$41.00 millionP/E RatioN/ADividend YieldN/APrice Target$5.00Consensus RatingModerate Buy Company Overview Rapid Micro Biosystems, Inc. develops automated solutions for microbial quality control in pharmaceutical, biotechnology, and other regulated manufacturing environments. Its technologies are designed to help manufacturers detect, enumerate, and monitor microorganisms while reducing manual laboratory work and supporting faster release of products and production areas. The company’s primary platform is the Growth Direct System, an automated microbial detection and enumeration system used for applications such as environmental monitoring and bioburden testing. Rapid Micro Biosystems also provides related consumables, software, data-management capabilities, and service and support offerings intended to integrate microbial testing into customers’ quality-control workflows. Founded in 2006 and headquartered in Lowell, Massachusetts, Rapid Micro Biosystems serves customers in the biopharmaceutical and related life sciences industries. The company’s solutions are marketed internationally, supporting manufacturing operations across North America, Europe, and other global regions. Rapid Micro Biosystems became a publicly traded company on the Nasdaq exchange in 2021 under the symbol RPID.AI Generated. May Contain Errors. Read More Rapid Micro Biosystems Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks72nd Percentile Overall ScoreRPID MarketRank™: 3.57705434497 of 5 starsRapid Micro Biosystems scored higher than 72% of companies evaluated by MarketBeat, and ranked 210th out of 873 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.8 / 5Analyst RatingModerate Buy Consensus RatingRapid Micro Biosystems has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 1 strong buy rating, 2 buy ratings, no hold ratings, and 1 sell rating.Upside PotentialRapid Micro Biosystems has a consensus price target of $5.00, representing about 511.8% upside from its current price of $0.82.Amount of Analyst CoverageRapid Micro Biosystems has only been the subject of 2 research reports in the past 90 days.Read more about Rapid Micro Biosystems' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Rapid Micro Biosystems are expected to grow in the coming year, from ($0.94) to ($0.72) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Rapid Micro Biosystems is -0.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Rapid Micro Biosystems is -0.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioRapid Micro Biosystems has a P/B Ratio of 1.09. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Rapid Micro Biosystems' valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.95% of the float of Rapid Micro Biosystems has been sold short.Short Interest Ratio / Days to CoverRapid Micro Biosystems has a short interest ratio ("days to cover") of 2.28, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Rapid Micro Biosystems has recently decreased by 9.19%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldRapid Micro Biosystems does not currently pay a dividend.Dividend GrowthRapid Micro Biosystems does not have a long track record of dividend growth. News and Social Media3.1 / 5News SentimentN/A News SentimentRapid Micro Biosystems has a news sentiment score of 0.91. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.71 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 1 news article for Rapid Micro Biosystems this week, compared to 2 articles on an average week.MarketBeat Follows1 people have added Rapid Micro Biosystems to their MarketBeat watchlist in the last 30 days. Company Ownership1.1 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Rapid Micro Biosystems insiders have not sold or bought any company stock.Percentage Held by Insiders12.70% of the stock of Rapid Micro Biosystems is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions52.60% of the stock of Rapid Micro Biosystems is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Rapid Micro Biosystems' insider trading history. Receive RPID Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Rapid Micro Biosystems and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RPID Stock News HeadlinesRapid Micro Biosystems consensus price target cut by 13.75% to $5.86October 2, 2026 | msn.comRapid Micro Biosystems to Participate in Upcoming Investor ConferencesSeptember 4, 2026 | globenewswire.comA new income category is drawing serious money - here's whyForbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the eye-popping yields are fueling a boom among everyday investors. Three years ago, barely a dozen of these funds existed - today there are more than 100, holding over $140 billion. These funds trade on the NYSE and NASDAQ and are built to generate monthly income. Some investors are targeting $5,000 a month with roughly one-tenth of the nest egg Wall Street says you need.October 14 at 1:00 AM | Investors Alley (Ad)Rapid Micro Biosystems, Inc. Q2 2026 Earnings Call SummaryAugust 8, 2026 | finance.yahoo.comRapid Micro Biosystems Reports Second Quarter 2026 Financial ResultsAugust 7, 2026 | globenewswire.comRapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)August 4, 2026 | globenewswire.comRapid Micro Biosystems to Announce Second Quarter 2026 Financial Results on August 7, 2026July 23, 2026 | globenewswire.comRapid Micro Biosystems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)June 10, 2026 | markets.businessinsider.comSee More Headlines RPID Stock Analysis - Frequently Asked Questions How have RPID shares performed this year? Rapid Micro Biosystems' stock was trading at $2.90 at the beginning of the year. Since then, RPID stock has decreased by 71.8% and is now trading at $0.8173. How were Rapid Micro Biosystems' earnings last quarter? Rapid Micro Biosystems, Inc. (NASDAQ:RPID) released its earnings results on Friday, August, 7th. The company reported ($0.27) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.24) by $0.03. The company had revenue of $8.05 million for the quarter, compared to the consensus estimate of $7.88 million. Rapid Micro Biosystems had a negative trailing twelve-month return on equity of 177.04% and a negative net margin of 145.56%. Read the conference call transcript. When did Rapid Micro Biosystems IPO? Rapid Micro Biosystems (RPID) raised $150 million in an initial public offering (IPO) on Wednesday, July 14th 2021. The company issued 7,920,000 shares at $18.00-$20.00 per share. How do I buy shares of Rapid Micro Biosystems? Shares of RPID stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Rapid Micro Biosystems own? Based on aggregate information from My MarketBeat watchlists, some other companies that Rapid Micro Biosystems investors own include Advanced Micro Devices (AMD), NVIDIA (NVDA), Star Bulk Carriers (SBLK), Tesla (TSLA), Intel (INTC), ASML (ASML) and Broadcom (AVGO). Company Calendar Last Earnings8/07/2026Today10/14/2026Next Earnings (Estimated)11/06/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Life Sciences Tools & Services Sub-IndustryLife Sciences Tools & Services Current SymbolNASDAQ:RPID CIK1380106 Webwww.rapidmicrobio.com Phone978-349-3200FaxN/AEmployees171Year FoundedN/APrice Target and Rating Average Price Target for Rapid Micro Biosystems$5.00 High Price Target$7.00 Low Price Target$3.00 Potential Upside/Downside+511.8%Consensus RatingModerate Buy Rating Score (0-4)2.75 Research Coverage4 Analysts Profitability EPS (Trailing Twelve Months)($1.12) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$47.12 million Net Margins-145.56% Pretax Margin-145.34% Return on Equity-177.04% Return on Assets-73.12% Debt Debt-to-Equity Ratio1.08 Current Ratio2.55 Quick Ratio1.51 Sales & Book Value Annual Sales$33.59 million Price / Sales1.22 Cash FlowN/A Price / Cash FlowN/A Book Value$0.75 per share Price / Book1.09Miscellaneous Outstanding Shares50,160,000Free Float43,790,000Market Cap$41.00 million OptionableNot Optionable Beta1.50 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (NASDAQ:RPID) was last updated on 10/14/2026 by MarketBeat.com Staff. From Our PartnersDo this before December or regret itPorter Stansberry believes President Trump will use the December G20 Summit in Miami to unveil a radical monet...Porter & Company | SponsoredA new income category is drawing serious money - here's whyForbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the ...Investors Alley | SponsoredElon's next millionaires start October 24?SpaceX minted 4,400 millionaires in a single day, and Tesla has turned more than 5,000 employees into milliona...Behind the Markets | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredElon Musk’s One Stock Retirement PlanJeff Brown picked Nvidia in 2016, before it surged 37,000 percent. Now he's tracking a small AI company he say...Brownstone Research | SponsoredBezos… DOOMEDA single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X com...Paradigm Press | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rapid Micro Biosystems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rapid Micro Biosystems With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.